Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
RSC Chemical Biology|July 22, 2022
Molecular design of near-infrared (NIR) fluorescent probes targeting exopeptidase and application for detection of dipeptidyl peptidase 4 (DPP-4) activityYuki Hoshino, Kenjiro Hanaoka, Kei Sakamoto, et al.
Journal of Surgical Oncology|December 30, 2024
Association of Preoperative Physical Fitness With Post-Esophagectomy Pneumonia in Older With Locally Advanced Esophageal Cancer: An Exploratory Prospective StudyTsuyoshi Harada, Tetsuya Tsuji, Junya Ueno, et al.
BMC Cancer|June 8, 2021
REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancerHiromichi Nakajima, Daisuke Kotani, Hideaki Bando, et al.
Therapeutic Advances in Medical Oncology|August 1, 2020
Clinical and molecular factors for selection of nivolumab or irinotecan as third-line treatment for advanced gastric cancerTakahiro Ishii, Akihito Kawazoe, Akinori Sasaki, et al.
Investigational New Drugs|May 21, 2021
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first-line treatment for metastatic colorectal cancer: Safety lead-in results from the QUATTRO-II studyDaisuke Kotani, Takayuki Yoshino, Masahito Kotaka, et al.
ESMO Open|July 29, 2020
Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancerAkinori Sasaki, Akihito Kawazoe, Testuya Eto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
The Impact of Molecular Subtype on Efficacy of Chemotherapy and Checkpoint Inhibition in Advanced Gastric CancerYohei Kubota, Akihito Kawazoe, Akinori Sasaki, et al.
The Oncologist|July 7, 2021
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational StudyKeigo Chida, Daisuke Kotani, Toshiki Masuishi, et al.
Journal of Gastroenterology|May 31, 2024
Definitive chemoradiotherapy induces T-cell-inflamed tumor microenvironment in unresectable locally advanced esophageal squamous cell carcinomaTakumi Habu, Shogo Kumagai, Hideaki Bando, et al.
Radiation Oncology Journal|April 7, 2026
Prognostic significance of the neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma treated with proton beam therapyKenji Makita, Hidehiro Hojo, Hidenari Hirata, et al.
Pageof 9